These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 29598855)

  • 1. Role of Percutaneous Coronary Intervention in the Treatment of Cardiac Allograft Vasculopathy.
    Lee MS; Lluri G; Finch W; Park KW
    Am J Cardiol; 2018 May; 121(9):1051-1055. PubMed ID: 29598855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term clinical outcomes in patients treated with drug-eluting compared to bare-metal stents for the treatment of transplant coronary artery disease.
    Lee MS; Yang T; Kandzari D; Mahmud E; Liao H; Kirtane A
    Catheter Cardiovasc Interv; 2012 Oct; 80(4):533-8. PubMed ID: 21953766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcomes of heart transplantation recipients with transplant coronary artery disease who develop in-stent restenosis after percutaneous coronary intervention.
    Lee MS; Cheng RK; Kandzari DE; Kirtane AJ
    Am J Cardiol; 2012 Jun; 109(12):1729-32. PubMed ID: 22465319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Sex on Outcomes Among Patients With Cardiac Allograft Vasculopathy Who Undergo Percutaneous Coronary Intervention.
    Lee MS; Wadia SK; Shlofmitz R
    J Invasive Cardiol; 2020 Dec; 32(12):453-458. PubMed ID: 33221733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term clinical and angiographic outcomes of percutanenous coronary intervention with everolimus-eluting stents for the treatment of cardiac allograft vasculopathy.
    Cheng R; Vanichsarn C; Patel JK; Currier J; Chang DH; Kittleson MM; Makkar R; Kobashigawa JA; Azarbal B
    Catheter Cardiovasc Interv; 2017 Jul; 90(1):48-55. PubMed ID: 27862865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of percutaneous coronary intervention with bare-metal and drug-eluting stents for cardiac allograft vasculopathy.
    Lee MS; Kobashigawa J; Tobis J
    JACC Cardiovasc Interv; 2008 Dec; 1(6):710-5. PubMed ID: 19463388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes after percutaneous coronary intervention of left main coronary artery for treatment of cardiac allograft vasculopathy after orthotopic heart transplantation.
    Lee MS; Yang T; Fearon WF; Ho M; Tarantini G; Xhaxho J; Gerosa G; Weston M; Ehdaie A; Rabbani L; Kirtane AJ
    Am J Cardiol; 2010 Oct; 106(8):1086-9. PubMed ID: 20920643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sirolimus- versus paclitaxel-eluting stents for the treatment of cardiac allograft vasculopathy.
    Lee MS; Tarantini G; Xhaxho J; Yang T; Ehdaie A; Bhatia R; Favaretto E; Tobis J
    JACC Cardiovasc Interv; 2010 Apr; 3(4):378-82. PubMed ID: 20398863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcomes after stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 10-year results of bare-metal stents and 5-year results of drug-eluting stents from the ASAN-MAIN (ASAN Medical Center-Left MAIN Revascularization) Registry.
    Park DW; Kim YH; Yun SC; Lee JY; Kim WJ; Kang SJ; Lee SW; Lee CW; Kim JJ; Choo SJ; Chung CH; Lee JW; Park SW; Park SJ
    J Am Coll Cardiol; 2010 Oct; 56(17):1366-75. PubMed ID: 20946993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous coronary artery revascularization procedures in pediatric heart transplant recipients: A large single center experience.
    Turner ME; Addonizio LJ; Richmond ME; Zuckerman WA; Vincent JA; Torres AJ; Collins MB
    Catheter Cardiovasc Interv; 2016 Nov; 88(5):797-803. PubMed ID: 27083510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of drug-eluting balloons alone or in combination with drug-eluting stents in the treatment of de novo diffuse coronary disease.
    Costopoulos C; Latib A; Naganuma T; Sticchi A; Figini F; Basavarajaiah S; Carlino M; Chieffo A; Montorfano M; Naim C; Kawaguchi M; Giannini F; Colombo A
    JACC Cardiovasc Interv; 2013 Nov; 6(11):1153-9. PubMed ID: 24262615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcomes of percutaneous coronary intervention in transplant coronary artery disease in pediatric heart transplant recipients.
    Lee MS; Sachdeva R; Kim MH; Sachdeva R
    J Invasive Cardiol; 2012 Jun; 24(6):278-81. PubMed ID: 22684382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of drug-eluting and bare-metal stents for primary percutaneous coronary intervention with or without abciximab in ST-segment elevation myocardial infarction: DEBATER: the Eindhoven reperfusion study.
    Wijnbergen I; Helmes H; Tijssen J; Brueren G; Peels K; van Dantzig JM; Van' t Veer M; Koolen JJ; Pijls NH; Michels R
    JACC Cardiovasc Interv; 2012 Mar; 5(3):313-22. PubMed ID: 22440498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcome after surgical or percutaneous revascularization in coronary bypass graft failure.
    Harskamp RE; Beijk MA; Damman P; Kuijt WJ; Woudstra P; Grundeken MJ; Kloek JJ; Tijssen JG; de Mol BA; de Winter RJ
    J Cardiovasc Med (Hagerstown); 2013 Jun; 14(6):438-45. PubMed ID: 22828774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison on the long-term outcomes post percutaneous coronary intervention or coronary artery bypass grafting for bifurcation lesions in unprotected left main coronary artery].
    Yang BG; Yu XP; Chen F; Lyu SZ; Li Q; He JQ; Yuan F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):19-25. PubMed ID: 28100341
    [No Abstract]   [Full Text] [Related]  

  • 16. Unprotected left main coronary artery percutaneous coronary intervention in a pediatric patient with cardiac allograft vasculopathy.
    Tadwalkar RV; Lee MS
    J Invasive Cardiol; 2014 Nov; 26(11):E156-60. PubMed ID: 25364007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-eluting stents may not reduce target lesion revascularization in cardiac allograft vasculopathy.
    Park KE; Huo T; Muller KE; Aranda JM; Hill JA; Anderson RD
    J Interv Cardiol; 2014 Feb; 27(1):80-5. PubMed ID: 24383617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-eluting stenting of unprotected left main coronary artery stenosis in patients with orthotopic heart transplantation: Initial clinical experience.
    Lee MS; Chun KJ; Tobis JM
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):306-11. PubMed ID: 18288757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-eluting versus bare-metal stents in large coronary arteries of patients with ST-segment elevation myocardial infarction: findings from the ICAS registry.
    Abe D; Sato A; Hoshi T; Maruta S; Misaki M; Kakefuda Y; Watabe H; Hiraya D; Sakai S; Kawabe M; Takeyasu N; Aonuma K
    J Cardiol; 2014 Nov; 64(5):377-83. PubMed ID: 24685689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting in Patients With Left Main Coronary Artery Stenosis: A Systematic Review and Meta-analysis.
    Giacoppo D; Colleran R; Cassese S; Frangieh AH; Wiebe J; Joner M; Schunkert H; Kastrati A; Byrne RA
    JAMA Cardiol; 2017 Oct; 2(10):1079-1088. PubMed ID: 28903139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.